Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lawrence A. Kenyon currently holds 5,946 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence A. Kenyon has been a net seller of ONS stock. They have purchased $122.6K and sold $583.3K worth of shares.
Lawrence A. Kenyon's most recent insider trade was on Sep 26, 2024, when they purchased 5,000 shares at $5.69 per share.
Lawrence A. Kenyon serves as Executive at Oncobiologics, Inc. (ONS). They have executed 38 insider transactions totaling $706.0K over their tenure at the company.
Lawrence A. Kenyon holds the position of Executive at Oncobiologics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Lawrence A. Kenyon has shown a selling trading pattern, with $122.6K in total purchases and $583.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lawrence A. Kenyon was on Mar 3, 2010, when they sold $280.0K worth of PRX shares. This transaction involved 21,439 shares at $13.06 per share.
Lawrence A. Kenyon currently owns 5,946 shares of Oncobiologics, Inc. (ONS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lawrence A. Kenyon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence A. Kenyon has 38 Form 4 filings on record as an insider at Oncobiologics, Inc..
Set alerts for Lawrence A. Kenyon and 40,000+ other insiders.